Novo Nordisk A S
NONOF- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0000353278
No open-market purchases or sales by Novo Nordisk A S insiders were filed in the last 90 days; 3 institutions reported holding it in 13F filings for Q2 2026, worth $5.36M in total; no superinvestor holds it.
Other share classesNVO
Q1 2025 vs. Q4 2024
How the institutions holding Novo Nordisk A S changed between Q4 2024 and Q1 2025.
All holders in Q1 2025All holders in Q4 2024
| Measure | Q4 2024 | Q1 2025 | Change |
|---|---|---|---|
| Holders | 3 | 2 | −1 |
| Shares | 16.2K | 12.5K | −3.74K (−23.1%) |
| Value | $1.39M | $849.3K | −$542.8K (−39.0%) |
New holders (0)
Institutions that held Novo Nordisk A S at the end of Q1 2025 but not at the end of Q4 2024.
None.
Sold out (1)
Institutions that held Novo Nordisk A S at the end of Q4 2024 and filed for Q1 2025 without it.
| Institution | Shares, Q4 2024 | Value, Q4 2024 |
|---|---|---|
| GAMMA Investing LLC | 778 | $66.8K |